NASDAQ:IXHL - Nasdaq - US45333F1093 - Common Stock - Currency: USD
NASDAQ:IXHL (4/21/2025, 8:23:28 PM)
0.59
-0.01 (-1.68%)
The current stock price of IXHL is 0.59 USD. In the past month the price decreased by -28.8%. In the past year, price decreased by -73.42%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 62.92 | 775.47B | ||
JNJ | JOHNSON & JOHNSON | 15.61 | 378.15B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 16.91 | 258.93B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.92 | 218.33B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 16.12 | 207.41B | ||
MRK | MERCK & CO. INC. | 10.19 | 195.90B | ||
PFE | PFIZER INC | 7.09 | 125.00B | ||
SNY | SANOFI-ADR | 11.42 | 124.68B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 42.93 | 99.58B | ||
GSK | GSK PLC-SPON ADR | 8.42 | 73.86B | ||
ZTS | ZOETIS INC | 24.81 | 65.50B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 32.46 | 46.99B |
Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. The company is headquartered in New York City, New York and currently employs 9 full-time employees. The company went IPO on 2022-03-18. The firm is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, and pain, among other indications. The Company’s diversified portfolio includes 28 distinct research and development (R&D) programs, and six clinical trials underway. Its clinical projects include IHL-42X Obstructive Sleep Apnea, IHL-675A Inflammatory Lung Disease, IHL-675A Rheumatoid Arthritis, IHL-675A Inflammatory Bowel Disease, IHL-216A Concussion and TBI, PSI-GAD Psilocybin for anxiety, MedChew GB Post-herpatic Neuralgia and MedChew -1401 Pain and Spasticity in Multiple Sclerosis.
INCANNEX HEALTHCARE INC
18 East 50th Street, 5th Floor
New York City NEW YORK US
Employees: 9
Company Website: http://www.incannex.com
Investor Relations: http://www.incannex.com/sec-filings
The current stock price of IXHL is 0.59 USD. The price decreased by -1.68% in the last trading session.
The exchange symbol of INCANNEX HEALTHCARE INC is IXHL and it is listed on the Nasdaq exchange.
IXHL stock is listed on the Nasdaq exchange.
INCANNEX HEALTHCARE INC (IXHL) has a market capitalization of 16.25M USD. This makes IXHL a Nano Cap stock.
INCANNEX HEALTHCARE INC (IXHL) currently has 9 employees.
The Revenue of INCANNEX HEALTHCARE INC (IXHL) is expected to grow by 3817.05% in the next year. Check the estimates tab for more information on the IXHL EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IXHL does not pay a dividend.
INCANNEX HEALTHCARE INC (IXHL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.4).
The outstanding short interest for INCANNEX HEALTHCARE INC (IXHL) is 0.58% of its float. Check the ownership tab for more information on the IXHL short interest.
ChartMill assigns a fundamental rating of 2 / 10 to IXHL. IXHL may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months IXHL reported a non-GAAP Earnings per Share(EPS) of -1.4. The EPS increased by 64.01% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -214.35% | ||
ROE | -2466.94% | ||
Debt/Equity | 3.9 |
For the next year, analysts expect an EPS growth of -116.51% and a revenue growth 3817.05% for IXHL